Company Profiles

driven by the PitchBook Platform

Celtaxsys

Description

Provider of clinical-stage pharmaceutical development services intended to provide therapies to treat inflammation in rare and orphan designated diseases. The company's pharmaceutical development services include cystic fibrosi treatments, molecule drugs and other critical treatments, enabling patients to get cured from rare and serious inflammatory conditions.

2004

Founded

PRIVATE

Status

1-10

Employees

Series D

Latest Deal Type

$45M

Latest Deal Amount

$55.2M

Total Amount Raised

Description

Provider of clinical-stage pharmaceutical development services intended to provide therapies to treat inflammation in rare and orphan designated diseases. The company's pharmaceutical development services include cystic fibrosi treatments, molecule drugs and other critical treatments, enabling patients to get cured from rare and serious inflammatory conditions.

Website:

www.celtaxsys.com

Ownership Status

Privately held (backing)

Financing Status

Venture Capital-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

201 17th Street Suite 530 Atlanta, GA 30363United States +1 (470) 206-0153
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Celtaxsys's full profile, request a free trial.

Celtaxsys Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Celtaxsys Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Celtaxsys Investors (10)

Request access
Investor NameInvestor TypeHoldingInvestor SinceParticipating RoundsBoard
Seat
Contact
Info
Advanced Technology Development CenterAccelerator/IncubatorMinority000 0000000 0000
Cystic Fibrosis FoundationCorporationMinority000 0000000 0000
Domain AssociatesVenture CapitalMinority000 0000000 0000
Evia PartnersOtherMinority000 0000000 0000
Georgia Research AllianceGovernmentMinority000 0000000 0000
Advanced Technology Development Center Accelerator/Incubator
Cystic Fibrosis Foundation Corporation
Domain Associates Venture Capital
Evia Partners Other
Georgia Research Alliance Government

Celtaxsys Executive Team (6)

NameTitleBoard
Seat
Contact
Info
Greg DuncanChief Executive Officer, President and Board Member
William ReddickChief Financial Officer & Founder
Eric Springman Ph.DChief Scientific Officer
Angela WalshVice President, Finance
Ralph GrosswaldVice President of Operations
Greg Duncan Chief Executive Officer, President and Board Member
William Reddick Chief Financial Officer & Founder
Eric Springman Ph.D Chief Scientific Officer
Angela Walsh Vice President, Finance
Ralph Grosswald Vice President of Operations

Celtaxsys Board Members (9)

NameRepresentingRoleSinceContact
Info
Abel De La Rosa Ph.DCeltaxsysBoard Member000 0000
Gerald BrunkLumira CapitalManaging Director000 0000
Jan LodalSelfBoard Member000 0000
Khalil BarrageSelfBoard Member000 0000
Matthew DontzinSelfBoard Member000 0000
Abel De La Rosa Ph.D Board Member Celtaxsys
Gerald Brunk Managing Director Lumira Capital
Jan Lodal Board Member Self
Khalil Barrage Board Member Self
Matthew Dontzin Board Member Self
Request full access to PitchBook